Teva Pharmaceutical Industries, the world's largest maker of generic drugs, plans to eliminate about 5,000 jobs as it accelerates cost reductions amid growing competition for the company's best-selling product.
Teva to cut 5,000 jobs to speed up $2 billion in savings
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.